参考文献/References:
［1］Camus C, Vitale S, Loubatier C, et al. Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening［J］. J Clin Med,2018,7(12):530.
［2］Wang X, Huang X, Zhang Y. Involvement of Human Papillomaviruses in Cervical Cancer ［J］. Front Microbiol,2018, 9(9):2896.
［3］Ozturk M, Umudum H, Alanbay I, et al. Risk of HSIL (CIN 2-3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test［J］. Diagn Cytopathol,2016,44(12):969-974.
［4］Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications ［J］. Cancer Med,2018,7(10):5217-5236.
［5］Huh W K, Ault K A, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance ［J］. Gynecol Oncol,2015,136(2):178-182.
［6］刘国炳，刘欣，庞战军，等. 宫颈癌患者盆腔淋巴结HPV-DNA检测的临床意义［J］. 第一军医大学学报,2005，25(10):1236-1239.
［7］Sabeena S, Bhat P V, Kamath V, et al. Global human papilloma virus vaccine implementation: An update［J］. J Obstet Gynaecol Res,2018,44(6):989-997.
［8］Martin I W, Steinmetz H B, Lefferts C L, et al. Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens［J］. Pathogens,2012,1(1):30-36.
［9］Petry K U, Liebrich C, Luyten A, et al. Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers ［J］. Papillomavirus Res,2017,(4):85-89.
［10］Li B, Wang H, Yang D, et al. Prevalence and distribution of cervical human papillomavirus genotypes in women with cytological results from Sichuan province, China［J］. J Med Virol,2019,91(1):139-145.
［11］代廷耕，刘晓霞，李曼，等. HPV阴性的宫颈癌及癌前病变的原因分析 ［J］. 中国实验诊断学,2016，20 (3):519-521.
［12］Bosch F X, de Sanjose S. The epidemiology of human papillomavirus infection and cervical cancer［J］. Dis Markers,2007,23(4):213-227.
［13］Vassilakos P, Tran P L, Sahli R, et al. HPV-negative CIN3 and cervical cancer in Switzerland: any evidence of impact on screening policies?［J］. Swiss Med Wkly,2017,147（11）:w14559.
［14］Kuzmin I, Liu L, Dammann R, et al. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection［J］. Cancer Res,2003,63(8):1888-1893.
［15］于啸. HPV阳性和阴性宫颈癌细胞系基因表达谱的研究 ［D］. 青岛大学,2013.
［16］Stuqui B, Conceicao A L, Termini L, et al. The differential role of HTRA1 in HPV-positive and HPV-negative cervical cell line proliferation ［J］. BMC Cancer,2016,16(1):840.
［17］尹香花，苏悦，隋玉梅，等. HPV阴性的宫颈癌和癌前病变中p 14 ARF蛋白表达及其临床意义［J］. 中国妇幼保健,2011(36):5784-5786.
［18］Kehl T, Backes C, Kern F, et al. About miRNAs, miRNA seeds, target genes and target pathways［J］. Oncotarget,2017,8(63):107167-107175.
［19］万淑琼，张军. miRNA在HPV阳性和阴性宫颈癌组织之间的差异研究 ［J］. 海南医学院学报,2013，19(1):101-103.
［20］Park S, Eom K, Kim J, et al. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer ［J］. BMC Cancer,2017,17(1):658.
［21］Li B, Hu Y, Ye F, et al. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection ［J］. Int J Gynecol Cancer,2010,20(4):597-604.
［22］Melar-New M, Laimins L A. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins ［J］. J Virol,2010,84(10):5212-5221.
［23］Zheng Z, Gao Y. Down-regulation of lncRNA snaR is correlated with postoperative distant recurrence of HPV-negative cervical squamous cell carcinoma ［J］. Biosci Rep,2018,38(6):1-7.
［24］Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings ［J］. J Infect Dis,2010,202(12):1789-1799.
［25］李智敏，曾俐琴，彭秀红，等. 高危型HPV阴性子宫颈癌患者的临床病理特点［J］. 中华妇产科杂志,2016,51(9):683-687.
［26］Pirog E C, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma ［J］. Am J Pathol,2000,157(4):1055-1062.
［27］Talia K L, Stewart C, Howitt B E, et al. HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation ［J］. Am J Surg Pathol,2017,41(8):1023-1033.
［28］邹莲英，尹娣，吕佩. HPV阴性和HPV阳性子宫颈癌的临床特点及预后比较 ［J］. 华夏医学,2018，31(2):53-57.
相似文献/References:
[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[4]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[5]帅翰林,罗新.射频消融技术在治疗宫颈病变和宫颈人乳头瘤病毒感染中的作用[J].中国计划生育和妇产科,2013,(01):0.
SHUAI Han-lin,LUO Xin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[6]罗新,范瑾.hTERC基因检测技术在宫颈病变筛查中的地位[J].中国计划生育和妇产科,2013,(03):0.
LUO Xin,FAN Jin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[7]吴晓菁,谈军,李优云,等.广州市白云区流动人口育龄妇女HPV感染及宫颈病变的流行病学调查[J].中国计划生育和妇产科,2013,(03):0.
WU Xiao - jing,TAN Jun,LI You - yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[8]安红梅,张雯,邓继红,等.昆明地区高危HPV病毒载量与宫颈病变和宫颈癌相关性[J].中国计划生育和妇产科,2013,(03):0.
AN Hong - mei,ZHANG Wen,DENG Ji - hong *,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[9]闵爱萍,谢桂清,冷开容,等.Hepsin、Maspin在宫颈疾病中的表达及其临床意义[J].中国计划生育和妇产科,2013,(06):0.
Min Ai-ping,Xie Gui-qing,Leng Kai-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[10]代鸣,邹志梅,黄江平,等.九江地区9328例宫颈液基细胞学检查结果分析[J].中国计划生育和妇产科,2014,(01):0.
DAI Ming,ZOU Zhi-mei,HUANG Jiang-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(10):0.
[11]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[12]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[13]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.
[14]熊炜,陈萰.TCT和HPV-DNA联合检测在宫颈癌及癌前病变筛查中的应用价值[J].中国计划生育和妇产科,2015,(12):0.
XIONG Wei,CHEN Jian,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[15]宋磊,付晓宇.多型别人乳头瘤病毒感染与宫颈癌[J].中国计划生育和妇产科,2016,(10):0.
[16]丁小星,杨佩芳*,杨晓月,等.微小RNA在人乳头瘤病毒感染所致宫颈癌侵袭过程中的研究进展[J].中国计划生育和妇产科,2018,(4):21.
[17]聂小倩,张维娜,张盛苗,等.人乳头瘤病毒E 6/E 7信使核糖核酸表达与
宫颈病变病理级别相关性分析[J].中国计划生育和妇产科,2018,(4):40.
NIE Xiao-qian,ZHANG Wei-na,ZHANG Sheng-miao,et al.Correlation between expression level of human papillomavirus E6/E7 mRNA and pathological grades of cervical lesions[J].Chinese Journal of Family Planning & Gynecotokology,2018,(10):40.
[18]聂明月,叶红*.宫颈病变中人乳头瘤病毒相关微小RNA的研究进展[J].中国计划生育和妇产科,2020,(6):12.